Featured Research

from universities, journals, and other organizations

IVIG Infusion And A Living Kidney Donation From A Virtual Stranger Give A Hollywood Film Producer Another "Curtain Call"

Date:
January 10, 2000
Source:
Cedars-Sinai Medical Center
Summary:
The new millennium is one that film producer Jay Cohen, 38, may not have lived to see – except for the generosity of a stranger who donated one of her kidneys to him last July, and to a relatively new type of therapy that enabled Suzi Landolphi to donate a kidney even though her tissue did not match Jay’s. Both donor and recipient are back to work, doing well, feeling great, and available for interviews.

LOS ANGELES (January 4, 2000) – Thanks to the generosity of a virtual stranger who gave up one of her kidneys for him, and to a relatively new therapeutic approach, known as intravenous immunoglobulin (IVIG) that reduces the rejection risk of transplanted organs, Jay Cohen, 38, of Tarzana, CA, is enjoying the new year with his family -- with a healthy new kidney and a new lease on life. Despite the fact that a donor with an exact tissue match could not be found for him, Jay was successfully transplanted last July, is back to work and doing very well.

According to Dwight Makoff, M.D., Jay’s nephrologist at Cedars-Sinai Medical Center, what made this transplant unique was that the donor and the recipient were virtual strangers to each other. At least, they were strangers when they first met and the donor, Suzy Landolphi, offered one of her kidneys. Since then, though, they have become very good friends – teaming up to cheer each other on in what would be the fight of Jay’s life.

“In the hospital we went into pre-op together,” Suzi said. “We were lying side-by-side on gurneys, and I was asking him how he was feeling, and he was asking me the same thing. We were making each other laugh like two nervous athletes before the big game!”

When they came out of their respective surgeries after the transplant the first words out of Suzi’s mouth were “How’s Jay?” and the first question he asked was “How’s Suzi?”

The father of 3-year-old and 6-year-old daughters, Jay is a Hollywood film producer and has suffered with a lifelong kidney disease. When he turned 36, his creatinine levels began increasing. For a normal person, creatinine levels are at 1. Within nine months, though, Jay’s levels had soared to 13, and his condition worsened significantly. He began to experience severe and extremely painful leg cramps, daily nausea, weakness and weight loss – losing 30 pounds.

No stranger to the world of kidney disease, Jay’s two brothers had already had transplants. His wife, Laura, and other relatives offered to donate a kidney to him, but they were not suitable matches.

As he waited without a suitable donor available, Jay was placed on kidney dialysis three days a week for four hours each day. “I’d go in after work, from 4 – 9 p.m. on Mondays, Wednesdays, Fridays, and sometimes on Saturdays,” he said. “There, I would read scripts and make telephone calls.” During the five months that he was on dialysis, Jay lost another 10 pounds.

As time went on, a couple of friends offered to donate – one was not a match, and the other, while a match, backed out at the last minute. “I had such conflicting emotions,” Jay recalls now. “I knew I needed the transplant in order to live, but how could I ask someone – anyone – to make that kind of sacrifice? It’s just not the kind of thing you can ask of someone.”

Enter Suzi, a former radio talk show host, who is an expert on humor and sexuality and has appeared on a host of nationally syndicated television talk shows. Although Suzi’s husband, David Pritchard, knew Jay through work, the two men were not close friends, and Suzi didn’t know him at all. Then early this year, they happened to be attending a party that Jay and Laura were also attending. Something about him reached out to Suzi, and she couldn’t get him out of her mind. Several months later, on a Saturday morning, she turned to her husband and announced, “I want to give Jay one of my kidneys.” David gaped at her. “I was just going to tell you the same thing,” he said. “I want to give him one of mine.”

When they told Jay, though, his reaction was less than enthusiastic. “I had mixed feelings,” he remembers. “I’d had my hopes raised several times already, only to be dashed. I didn’t know if I could make it through another roller-coaster ride of waiting to see if our tissues were compatible, and then if they were, having the donor perhaps change her mind at the last minute. Plus, I wasn’t sure I wanted to have the responsibility of Suzi only having one kidney for the rest of her life.”

As it turned out, neither David nor Suzi were a suitable match for the transplant, but Suzi appeared to be a “closer match” than David, and Jay’s transplant surgeon, J. Louis Cohen, M.D. (no relation to Jay), sent them to see Stan Jordan, M.D., a nephrologist at Cedars-Sinai who pioneered the concept of using gammaglobulin in the transplant environment.

“Dr. Jordan made this transplant possible,” said Jay. “When we went through the initial tissue matching process to see if Suzi was a suitable donor, our tissues didn’t match. I basically had an antibody to Suzi’s kidney.” In the past, an incompatible cross-match generally meant no transplant. But Dr. Jordan was not about to give up so easily.

He decided to test Jay’s blood after an infusion of intravenous immunoglobulin (IVIG), a therapy that appears to be helpful in preventing rejection in difficult cases when other medications have failed.

Back in the late 1980s, as IVIG was becoming established as a therapy for immune system disorders, Dr. Jordan and other researchers at Cedars-Sinai Medical Center began to develop the concept of using gammaglobulin in a transplant environment. “IVIG treatment has given the gift of life to many patients – including Jay -- who would not have had a chance at transplantation or would have died or spent long periods of time on dialysis without the hope of a life-saving transplant,” Dr. Jordan said.

After treating Jay with IVIG therapy, Dr. Jordan tested again and found that Jay and Suzi were indeed a match. About 30 days after the transplant Jay needed one more IVIG treatment, and like all other kidney transplant recipients, he will take immune-suppresive drugs throughout his lifetime.

Jay is back to reading scripts, producing films and feeling great some five months after the transplant. And Suzi? She considers that while she may have lost a kidney, she gained two wonderful friends, and would do it again in a heartbeat. Then she adds as an afterthought, “I’d challenge anyone to try to keep up with me in kickboxing now!”

# # #

For media information and to arrange an interview, please call 1-800-396-1002. Thanks for not publishing this number in stories.


Story Source:

The above story is based on materials provided by Cedars-Sinai Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Cedars-Sinai Medical Center. "IVIG Infusion And A Living Kidney Donation From A Virtual Stranger Give A Hollywood Film Producer Another "Curtain Call"." ScienceDaily. ScienceDaily, 10 January 2000. <www.sciencedaily.com/releases/2000/01/000104174227.htm>.
Cedars-Sinai Medical Center. (2000, January 10). IVIG Infusion And A Living Kidney Donation From A Virtual Stranger Give A Hollywood Film Producer Another "Curtain Call". ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/01/000104174227.htm
Cedars-Sinai Medical Center. "IVIG Infusion And A Living Kidney Donation From A Virtual Stranger Give A Hollywood Film Producer Another "Curtain Call"." ScienceDaily. www.sciencedaily.com/releases/2000/01/000104174227.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins